Robotics is the branch of technology that deals with the design, construction, operation, and application of robots. Robots are machines capable of carrying out a complex series of actions automatically, either programmed by a computer or using artificial intelligence (AI). Robotics is used by retailers in warehouses, in-store, and for improving the logistics and delivery process. The leading adopters of robotics in retail and apparel are investing in logistics robots, industrial co-bots, and inspection, cleaning, and maintenance robots, to automate operations and improve efficiency.
This thematic report takes an in-depth look at the importance of robotics to the retail and apparel sector. Firstly, the value chain section provides an in-depth description of each segment of robotics and outlines the specialist vendors and leading adopters of robotics in the retail and apparel sector.
The challenges section outlines the key challenges currently faced by the retail and apparel sector. This is followed by an impact assessment detailing the areas in robotics where retail companies should focus and outlines how these challenges have accelerated the need for robotics.
The case study section highlights the deployment of robots within retail and apparel.
A data analysis section provides market size and growth forecasts, mergers and acquisition activity analysis, a robotics timeline, and insight into patents, company filings, and hiring trends.
Finally, the report profiles companies making their mark within the theme.
Robotics can help address the various challenges retailers face, such as the need to profile customers, achieve greater personalization, understand market trends, and improve operational efficiency. According to publisher forecasts, the global robotics market was worth $45.8 billion in 2020 and will grow at a compound annual growth rate (CAGR) of 29% between 2020 and 2030, reaching $568 billion by 2030.
Robotics is increasingly being used by high-growth industry leaders to improve warehouse efficiency, streamline their logistics and supply chain networks, and enable shorter delivery times for customers. Industrial robots are used in retail warehouses to take on heavy and repetitive tasks and co-bots are increasingly being used to work alongside human workers to process orders. Drones are also filling gaps in delivery systems, including reaching isolated areas.
Retailers are also adopting robotics instore to help converge online and offline retail. Managing store inventory is a major problem for many retailers, with inaccurate tracking leading to lost revenue. Robots can solve this problem through constant stock-taking and shelf audits, identifying stock shortages. As robotics becomes more technologically advanced and artificial intelligence (AI) develops, the level of accuracy in tasks undertaken by robots will consistently grow and create new efficiencies for retailers.
This thematic report takes an in-depth look at the importance of robotics to the retail and apparel sector. Firstly, the value chain section provides an in-depth description of each segment of robotics and outlines the specialist vendors and leading adopters of robotics in the retail and apparel sector.
The challenges section outlines the key challenges currently faced by the retail and apparel sector. This is followed by an impact assessment detailing the areas in robotics where retail companies should focus and outlines how these challenges have accelerated the need for robotics.
The case study section highlights the deployment of robots within retail and apparel.
A data analysis section provides market size and growth forecasts, mergers and acquisition activity analysis, a robotics timeline, and insight into patents, company filings, and hiring trends.
Finally, the report profiles companies making their mark within the theme.
Robotics can help address the various challenges retailers face, such as the need to profile customers, achieve greater personalization, understand market trends, and improve operational efficiency. According to publisher forecasts, the global robotics market was worth $45.8 billion in 2020 and will grow at a compound annual growth rate (CAGR) of 29% between 2020 and 2030, reaching $568 billion by 2030.
Robotics is increasingly being used by high-growth industry leaders to improve warehouse efficiency, streamline their logistics and supply chain networks, and enable shorter delivery times for customers. Industrial robots are used in retail warehouses to take on heavy and repetitive tasks and co-bots are increasingly being used to work alongside human workers to process orders. Drones are also filling gaps in delivery systems, including reaching isolated areas.
Retailers are also adopting robotics instore to help converge online and offline retail. Managing store inventory is a major problem for many retailers, with inaccurate tracking leading to lost revenue. Robots can solve this problem through constant stock-taking and shelf audits, identifying stock shortages. As robotics becomes more technologically advanced and artificial intelligence (AI) develops, the level of accuracy in tasks undertaken by robots will consistently grow and create new efficiencies for retailers.
Scope
- An overview of the robotics value chain including leaders and challengers for each sub-segment.
- A breakdown of the key challenges in the retail and apparel industry, and how robotics technologies can help to solve them.
- Market size and growth forecasts for robotics split into segments.
- Case studies showing the use cases for robotics across the retail and apparel industry.
- Analysis of alternative data including company filing, patent, and hiring activity.
- A review of the leading adopters of robotics in retail and apparel, the specialist robotics vendors for retail and apparel, and the leading robotics vendors cross-industry.
- Thematic scorecards ranking leading retail and apparel companies on their involvement in key themes, including robotics.
Reasons to Buy
- To understand robotics and its current and future impact on the retail and apparel industry.
- To understand how key challenges the retail and apparel sector faces have accelerated the need for the deployment of robotics.
- To identify the leading robotics adopters and specialist robotics vendors.
- The publisher's thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying important themes early, enabling companies to make the right investments ahead of the competition, and securing that all-important competitive advantage.
Table of Contents
1 Executive Summary2 Robotics Value Chain
2.1 Robot manufacturing
2.2 Hardware components
2.3 Software components
2.4 Robotics as a service
3 Retail and Apparel Challenges
3.1 The Impact of Robotics on Retail and Apparel
4 Case Studies
5 Data Analysis
5.1 Market size and growth forecasts
5.2 Mergers and acquisitions
5.3 Patent trends
5.4 Company filings trends
5.5 Hiring trends
6 Robotics timeline
7 Companies
7.1 Leading robotics adopters in retail and apparel
7.2 Leading robotics vendors
7.3 Specialist robotics vendors in retail and apparel
8 Sector Scorecard
8.1 Retail sector scorecard
9 Glossary
10 Further Reading
11 Our Thematic Research Methodology
12 About the Publisher
13 Contact the Publisher
List of Tables
- Table 1: Approved Biosimilars, Australia, 2021
- Table 2: Major Therapeutic Areas by Pharmaceutical Sales ($B), Australia, 2019
- Table 3: COVID-19 Indicators (Number of Cases), Global and Australia, 2020-2021
- Table 4: COVID-19-Related Travel Restrictions, Australia, 2020-2021
- Table 5: COVID-19 Vaccine Trials, Australia, 2020-2021
- Table 6: COVID-19 Approved Vaccines, Australia, 2021
- Table 7: COVID-19 Vaccines Undergoing Evaluation, Australia, 2021
- Table 8: COVID-19 Treatments: Provisional Determinations, Australia, 2021
- Table 9: COVID-19 Treatments: Provisional Registrations, Australia, 2021
- Table 10: COVID-19 Drugs: Drugs Undergoing Evaluation, Australia, 2021
- Table 11: Pipeline Medical Devices for COVID-19, Australia, 2020-2021
- Table 12: COVID-19 Rapid Self Tests, Australia, 2021
- Table 13: Medical Devices Market, Australia, Major Segments ($B), 2020
- Table 14: Hospital Supplies Market, Australia, Revenue ($M) and Market Share (%) of Major Companies, 2020
- Table 15: Orthopedic Devices Market, Australia, Revenue ($M) and Market Share (%) of Major Companies, 2020
- Table 16: General Surgery Devices Market, Australia, Revenue ($M) and Market Share (%) of Major Companies, 2020
- Table 17: Cardiovascular Devices Market, Australia, Revenue ($M) and Market Share (%) of Major Companies, 2020
- Table 18: Anesthesia and Respiratory Devices Market, Australia, Revenue ($M) and Market Share (%) of Major Companies, 2020
- Table 19: Principles of Australian Government HTA Processes, Australia, 2021
- Table 20: MSN Thresholds, Australia, 2021
- Table 21: Customer Made Payment Before and After Thresholds, Australia, 2021
- Table 22: Medicare Levy Surcharge Rate, Australia, 2021
- Table 23: Difference in the Services offered by Public and Private Insurance, Australia, 2021
- Table 24: Costs of Wholesale Mark-Up, Australia, 2020
- Table 25: Dispensing Price for Highly Specialized Drugs, Australia, 2013-2020
- Table 26: AHI Fee, Australia, 2020
- Table 27: Annual Charges for Prescription Medicines, Australia, 2021
- Table 28: Priority Review Pathway for Prescription Medicines, Australia, 2021
- Table 29: Standard Prescription Medicine Fees, Australia, 2021
- Table 30: Fees for Applications, Australia, 2021
- Table 31: Classification of Medial Devices (Not IVD Medical Devices), Australia, 2021
- Table 32: Classification of IVD Medial Devices, Australia, 2021
- Table 33: Application Fees for Medical Devices, Australia, 2021
- Table 34: Annual Charges for IVD Medical Devices, Australia, 2021
- Table 35: Annual Charges of Medical Devices, Australia, 2021
- Table 36: Patent Examination Fees, Australia, 2021
- Table 37: Application Fee for Patent Filing, Australia, 2021
- Table 38: International Patent Fees, Australia, 2021
- Table 39: Opposition and Hearing Fees, Australia, 2021
- Table 40: Application Fee for the Trademark using the TM Headstart, Australia, 2021
- Table 41: Trademark Application Fee through the Standard Filing Procedure, Australia, 2021
- Table 42: Fees for Trademark Renewal, Australia, 2021
- Table 43: Annual Charges of Manufacturing License, Australia, 2021
- Table 44: Fees of Australian Manufacturing License, Australia, 2021
- Table 45: GMP Clearance Fees, Australia, 2021
- Table 46: Fees for Export Only Listed Medicines, Australia, 2021
- Table 47: Fees for Export Certification for Medicines, Australia, 2021
- Table 48: Fees for Export Certification for Medical Devices, Australia, 2021
- Table 49: Fees for Export Only Devices, Australia, 2021
- Table 50: Trade Fairs, Australia
- Figure 1: Pharmaceutical Market, Australia, Revenue ($B and AUDB), 2013-2020
- Figure 2: Medical Devices Market, Australia, Revenue ($B), 2016-2020
- Figure 3: Healthcare Startups in Australia, 2020
- Figure 4: Country Profile, Australia, 2020
- Figure 5: Pharmaceutical Market, Australia, Revenue ($B and AUDB), 2013-2020
- Figure 6: Pharmaceutical Market, Australia, Revenue Forecast ($B and AUDB), 2021-2026
- Figure 7: Pharmaceutical Exports ($B), Australia, 2013-2020
- Figure 8: Top Export Partners, Australia, 2020
- Figure 9: Pharmaceutical Imports ($B), Australia, 2013-2020
- Figure 10: Top Import Partners, Australia, 2020
- Figure 11: Pharmaceutical Supply Channel, Australia, 2021
- Figure 12: Process of eTP, Australia, 2021
- Figure 13: Principles of GBMA, Australia, 2021
- Figure 14: Facts Regarding Generics, Australia, 2021
- Figure 15: Working of Price Disclosure, Australia, 2021
- Figure 16: Number of Biosimilars Approved, Australia, 2010-2021
- Figure 17: OTC Market, Revenue ($B), Australia, 2013-2020
- Figure 18: OTC Medicines Market, Major Distribution Channels ($M), Australia, 2020
- Figure 19: OTC Medicines Market, Major Categories ($M), Australia, 2020
- Figure 20: Major Therapeutic Areas by Production Value, Australia, 2019
- Figure 21: COVID-19 Cases, Australia, 2020-2021
- Figure 22: COVID-19 Deaths, Australia, 2020-2021
- Figure 23: COVID-19 Stringency Index, Australia, 2020-2021
- Figure 24: Containment and Health Index, COVID-19, Australia, 2020-2021
- Figure 25: COVID-19 Fiscal Stimulus Timeline, Australia, 2020-2021
- Figure 26: COVID-19 Vaccine Doses Administration, Number of Vaccine Doses Administered, Australia, 2021
- Figure 27: Five Key Areas of Australia’s COVID-19 Vaccine and Treatment Strategy, Australia, 2020-2021
- Figure 28: COVID-19 Vaccine Plan, Australia, 2021
- Figure 29 Objectives of COVID-19 Vaccine Safety Monitoring Plan, Australia, 2021
- Figure 30: Vaccine Doses, Australia, 2021
- Figure 31: National Plan to Transition Australia’s National COVID-19 Response, Australia, 2021
- Figure 32: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Australia, 2020-2021
- Figure 33: Top COVID-19 Products by Device Class (Number of Available Marketed Products), Australia, 2020-2021
- Figure 34: Top COVID-19 IVD Products by Equipment Type (Number of Available Marketed Products), Australia, 2020-2021
- Figure 35: Top COVID-19 Hospital Supplies Products by Equipment Type (Number of Available Marketed Products), Australia, 2020-2021
- Figure 36: COVID-19 Clinical Trials Count by Trial Status, Australia, 2020-2021
- Figure 37: COVID-19 Clinical Trials Count by Market Categories, Australia, 2020-2021
- Figure 38: Top COVID-19 Clinical Trials Sponsors by Trial Count, Australia, 2020-2021
- Figure 39: Medical Devices Market, Australia, Revenue ($B), 2016-2020
- Figure 40: Medical Devices Market, Australia, Revenue ($B), 2021-2027
- Figure 41: Medical Devices Market, Australia, Major Segments (%), 2020
- Figure 42: Hospital Supplies Market, Australia, Revenue ($B), 2017-2025
- Figure 43: Hospital Supplies Market, Australia, Market Share of Major Players (%), 2020
- Figure 44: Orthopedic Devices Market, Australia, Revenue ($B), 2017-2025
- Figure 45: Orthopedic Devices Market, Australia, Market Share of Major Players (%), 2020
- Figure 46: General Surgery Devices Market, Australia, Revenue ($B), 2017-2025
- Figure 47: General Surgery Devices Market, Australia, Market Share of Major Players (%), 2020
- Figure 48: Cardiovascular Devices Market, Australia, Revenue ($B), 2017-2025
- Figure 49: Cardiovascular Devices Market, Australia, Market Share of Major Players (%), 2020
- Figure 50: Anesthesia and Respiratory Devices Market, Australia, Revenue ($B), 2017-2025
- Figure 51: Anesthesia and Respiratory Devices Market, Australia, Market Share of Major Players (%), 2020
- Figure 52: Diagnostic Market, Australia, Revenue ($B), 2015-2020
- Figure 53: Diagnostic Market, Australia, Revenue ($B), 2021-2025
- Figure 54: Medical Devices Market, Australia, Revenue ($B) of Major Companies, 2020
- Figure 55: Deal Value and Deal Count, Pharmaceutical Market, Australia, 2020-2021
- Figure 56: Deal Value and Deal Count Subtypes, Pharmaceutical Market, Australia, 2020-2021
- Figure 57: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Australia, 2020-2021
- Figure 58: Top Therapy Areas by Deal Value, Pharmaceutical Market, Australia, 2020-2021
- Figure 59: Top Therapy Areas by Deal Count, Pharmaceutical Market, Australia, 2020-2021
- Figure 60: M&A Deals by Quarter, Pharmaceutical Market, Australia, 2020-2021 (by Value and by Number)
- Figure 61: VC Deals by Quarter, Pharmaceutical Market, Australia, 2020-2021 (by Value and by Number)
- Figure 62: Deal Value and Deal Count, Medical Devices Market, Australia, 2020-2021
- Figure 63: Deal Value and Deal Count Subtypes, Medical Devices Market, Australia, 2020-2021
- Figure 64: Deal Value and Deal Count, Quarterly, Medical Devices Market, Australia, 2020-2021
- Figure 65: Top Equipment Sectors by Deal Value, Medical Devices Market, Australia, 2020-2021
- Figure 66: Top Equipment Sectors by Deal Count, Medical Devices Market, Australia, 2020-2021
- Figure 67: M&A Deals by Quarter, Medical Devices Market, Australia, 2020-2021 (by Value and by Number)
- Figure 68: VC Deals by Quarter, Medical Devices Market, Australia, 2020-2021 (by Value and by Number)
- Figure 69: Benefits of Digital Health, Australia, 2020
- Figure 70: Deal Value ($M) and Deal Count, HealthTech, Australia, 2020-2021
- Figure 71: Deal Value and Deal Count (Number of Deals) by sector, HealthTech, Australia, 2020-2021
- Figure 72: Key Themes of Australia’s National Digital Health Strategy, Australia, 2020
- Figure 73: Strategic Priorities of Australia’s National Digital Health Strategy, Australia, 2020
- Figure 74: Digital Health Today and Future Timeline as per the Digital Health Strategy, Australia, 2020
- Figure 75: Organization of Healthcare System, Australia, 2021
- Figure 76: HTA Process of Market Entry and Reimbursement, Australia, 2021
- Figure 77: Proportion of Benefits Paid by Hospital Cover Private Health Insurance by Service Type, (in $M) Australia, 2018-2019
- Figure 78: Proportion of Benefits Paid by General Cover Private Health Insurance by Service Type (in $M), Australia, 2018-2019
- Figure 79: OOP Expenditure (% of Total Expenditure on Health), Australia, 2013-2020
- Figure 80: Annual Rate of Change (%), Consumer Price Index, Australia, 2013-2021
- Figure 81: Organization of TGA, Australia, 2021
- Figure 82: Phases and Milestones of Registration of Prescription Medicines, Australia, 2021
- Figure 83 Process of Registration of OTC, Australia, 2021
- Figure 84: Process of Registration of Complimentary Medicines, Australia, 2021
- Figure 85: Process of Registration of Medical Devices, Australia, 2021
- Figure 86: Patent Approval Process, Australia, 2021
- Figure 87: Trademark Approval Process, Australia, 2021
- Figure 88: Fees for the CTN and CTA schemes of Clinical Trials, Australia, 2021
- Figure 89: Pharmaceutical Clinical Trials Count by Trial Status, Australia, 2020-2021
- Figure 90: Pharmaceutical Clinical Trials Count by Therapy Area, Australia, 2020-2021
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 6 River Systems
- ABB
- Abundant Robots
- Aerialtronics
- Agrobot
- Alibaba
- Amazon
- Ambarella
- American Robotics
- AppHarvest
- Atlas Copco
- Autel Robotics
- Baker Hughes
- Bear Robotics
- Boeing, Broadcom
- Brooks Automation
- C2RO
- Cambridge Medical Robotics
- Cisco
- Clearpath
- Cleveron
- Cognex
- Co-op
- Cyberdyne
- CyPhy
- Delair
- DHL
- DJI
- Dyson
- EcoRobotix
- Ekso Bionics
- Electrolux
- Elephant Robotics
- Estun
- ExRobotics
- FANUC
- Festo
- Flytrex
- Focal Meditech
- Ford
- Franka Emika
- FreeFly
- Geek+
- GreyOrange
- H&M
- Hahn Group
- Haier
- Harmonic Drive
- HollySys
- Honda
- Honda Robotics
- Honeywell
- Huawei
- Huntington Ingalls Industries
- Hyundai Motor
- Ikea
- Infineon
- Inset
- Intel
- iRobot
- JD.com
- John Deere
- Johnson & Johnson
- Kawasaki
- Keyence
- KOKS
- Kroger
- LG Electronics
- Lockheed Martin
- Lockheed Martin
- Lowe’s
- Maxon
- Medrobotics
- Medtronic
- Mic AG
- Midea
- Mitsubishi Motors
- Mujin
- Nabtesco
- Nachi-Fujikoshi
- Nike
- Nippon Ceramic
- Northrop Grumman
- Nuro
- NXP
- Ocado
- Omron
- Parker Hannifin
- Parrot
- Preferred Networks
- Qualcomm
- Rabbit Tractors
- ReWalk Robotics
- Robert Bosch
- Robotiq
- Rockwell Automation
- Samsung Electronics
- Seegrid
- Siasun
- Softbank
- Sony
- Starship Technologies
- Stellantis
- Stryker
- TE Connectivity
- Teradyne
- Textron
- Thales Group
- Toyota
- Ubtech
- United Robotics Group
- Vecna
- Walmart
- Wingcopter
- Yaskawa
- Yuneec
- Zimmer Biomet
- Zipline
- Zora Robotics
